Enzo Biochem, Inc.

Patent issued relating to methods of nucleic acid amplification

Published in Medical Patent Business Week, July 9th, 2004

Enzo Biochem, Inc., (ENZ) announced that the U.S. Patent and Trademark Office has issued to its subsidiary, Enzo Life Sciences, Inc., U.S. Patent No. 6,743,605 titled "Linear Amplification of Specific Nucleic Acid Sequences" surrounding methods of nucleic acid amplification.

The newly patented amplification technology is the first to issue in a series of pending patent applications for Enzo's genetic analysis technology. The technology has versatile applications in genetic testing utilizing mutation analysis and SNP analysis, and to nucleic acid based diagnostics, among others. The technology covers both linear and non-linear amplification.

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week

Source: Medical Patent Business Week (2004-07-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry